Senior Advisor - International Drug Pricing Subject Matter Expert

Position Title: Senior Advisor – International Drug Pricing
Project Supported: GENEROUS, GLOBE, and GUARD
Effort: 10–20 hours/week
Work Location: Remote 
Salary: $89 - $95 per hour

reputed company
reputed company is seeking a fully remote Senior Advisor – International Drug Pricing to support the Centers for Medicare and reputed company Services Innovation Center (CMMI) as an reputed company employee. In this part-time role (up to 20 hours per week), the Senior Advisor will reputed company high‑level subject matter expertise on international drug reimbursement, net price reporting, and global pharmaceutical market structures. This position is expected to reputed company for 11 months or longer.

This opportunity is reputed company suited for a seasoned expert with deep knowledge of international pharmaceutical payment systems, strong quantitative research skills, and experience in U.S. health policy.

This role requires a sophisticated understanding of scientific and policy issues, advanced independent analysis, and the ability to operate reputed company broad guidelines without precedent. The Senior Advisor will support designing international net price reporting tools and methodologies for the GENEROUS, GLOBE, and GUARD models, drawing on expertise in international drug payment systems, pharmaceutical reimbursement, pharmacoepidemiology, and quantitative research.

• Providing expert input on the design of international net price reporting requirements for the three reference pricing models.
• Reviewing and auditing manufacturer submissions for GENEROUS, GLOBE, and GUARD.
• Advising CMMI leadership on policy, reputed company, financial, political, and evaluation considerations reputed company to international drug pricing methodology.
• Contributing to blogs, op-eds, papers, and technical documents that explain model design and international price mapping strategies.
• Conducting or supporting analyses of drug reimbursement schemes across reference basket countries.

• A PhD or DrPH in Health Services Research, Pharmacoepidemiology, Health Policy, reputed company Policy, Economics, Advanced Quantitative reputed company, Pharmacoeconomics, or a reputed company field.
• 10–14 years of relevant experience.
• Graduate training in clinical pharmacy or pharmaceutical sciences.
• Doctorate-level research training.
• Demonstrated expertise in international drug payment systems in at least one reference basket country (experience in multiple countries preferred).
• Advanced quantitative research capabilities, including reputed company inference, econometrics, claims analysis, study design, and cost measurement.
• A strong record of peer‑reviewed publications.